Stock HONGSENG HONG SENG CONSOLIDATED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Hong Seng Consolidated

Equities

HONGSENG

MYQ0041OO002

Healthcare Facilities & Services

End-of-day quote BURSA MALAYSIA
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
0.01 MYR 0.00% Intraday chart for Hong Seng Consolidated 0.00% -60.00%
Apr. 19 Malaysian Shares Maintain Winning Streak; Key Alliance Group's Shares Balloon 100% MT
Apr. 08 Hong Seng Consolidated Berhad Announces the Appointment of Mr. Leong Seng Wui as Executive Director CI

Valuation

Fiscal Period: September 2018 2019 2020 2021 2022
Capitalization 1 61.06 51.77 582.5 6,177 1,660
Enterprise Value (EV) 1 62.47 49.24 531.4 6,034 1,599
P/E ratio -2.21 x -3.96 x -44.4 x 183 x 22.7 x
Yield - - - - -
Capitalization / Revenue 2.1 x 4.97 x 132 x 42.3 x 8.37 x
EV / Revenue 2.15 x 4.73 x 120 x 41.4 x 8.06 x
EV / EBITDA -26.2 x -79.4 x -263 x 157 x 24.6 x
EV / FCF - 26,674,286 x -190,469,778 x - -14,594,900 x
FCF Yield - 0% -0% - -0%
Price to Book 1.98 x 3.05 x 16.7 x 22.7 x 4.28 x
Nbr of stocks (in thousands) 1,061,943 1,061,943 2,061,944 5,104,874 5,108,417
Reference price 2 0.0575 0.0488 0.2825 1.210 0.3250
Announcement Date 7/31/18 7/29/19 8/24/20 1/27/22 1/30/23
1MYR in Million2MYR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2018 2019 2020 2021 2022
Net sales 1 29.11 10.41 4.429 145.9 198.4
EBITDA 1 -2.38 -0.62 -2.024 38.34 64.94
EBIT 1 -5.409 -1.648 -2.266 38.06 58.31
Operating Margin -18.58% -15.83% -51.16% 26.08% 29.39%
Earnings before Tax (EBT) 1 -25.99 -12.62 -7.458 66.99 119.2
Net income 1 -27.43 -13.07 -7.434 43.51 97.19
Net margin -94.25% -125.54% -167.84% 29.82% 48.99%
EPS 2 -0.0260 -0.0123 -0.006367 0.006618 0.0143
Free Cash Flow - 1.846 -2.79 - -109.6
FCF margin - 17.73% -62.99% - -55.23%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 7/31/18 7/29/19 8/24/20 1/27/22 1/30/23
1MYR in Million2MYR
Estimates

Balance Sheet Analysis

Fiscal Period: September 2018 2019 2020 2021 2022
Net Debt 1 1.41 - - - -
Net Cash position 1 - 2.53 51.1 143 60.9
Leverage (Debt/EBITDA) -0.5905 x - - - -
Free Cash Flow - 1.85 -2.79 - -110
ROE (net income / shareholders' equity) - -56.6% -19% - 29.9%
ROA (Net income/ Total Assets) - -3.21% -3.2% - 9.48%
Assets 1 - 407.3 232.5 - 1,025
Book Value Per Share 2 0.0300 0.0200 0.0200 0.0500 0.0800
Cash Flow per Share 2 0 0 0.0200 0.0300 0.0100
Capex 1 0.09 0.1 1.69 40.4 34.8
Capex / Sales 0.32% 0.92% 38.15% 27.71% 17.55%
Announcement Date 7/31/18 7/29/19 8/24/20 1/27/22 1/30/23
1MYR in Million2MYR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
HONG SENG CONSOLIDATED Stock Hong Seng Consolidated
-60.00% 10.71M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.58% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+15.05% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.49% 29.59B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-10.17% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-1.39% 16.36B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.58% 11.77B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+1.82% 11.72B
DAVITA INC. Stock DaVita Inc.
+31.86% 11.71B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-0.47% 11.66B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. HONGSENG Stock
  4. Financials Hong Seng Consolidated